Cost-Effectiveness of Hepatitis C Virus (HCV) Treatment With Telaprevir/Pegylated Interferon Alpha/Ribavirin Triple Therapy Versus Waiting for New Regimens in France
Value in Health - United Kingdom
doi 10.1016/j.jval.2013.08.1116
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2013
Authors
Publisher
Elsevier BV